164 related articles for article (PubMed ID: 25661085)
21. The role of SOX-2 on the survival of patients with non-small cell lung cancer.
Shao W; Chen H; He J
J Thorac Dis; 2015 Jul; 7(7):1113-8. PubMed ID: 26380725
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of β-catenin expression in patients with non-small cell lung cancer: a meta-analysis.
Mei XD; Su H; Song J; Dong L
Biosci Trends; 2013 Feb; 7(1):42-9. PubMed ID: 23524892
[TBL] [Abstract][Full Text] [Related]
24. High p27 expression is associated with a better prognosis in East Asian non-small cell lung cancer patients.
Zhuang Y; Yin HT; Yin XL; Wang J; Zhang DP
Clin Chim Acta; 2011 Nov; 412(23-24):2228-31. PubMed ID: 21878324
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
Au NH; Cheang M; Huntsman DG; Yorida E; Coldman A; Elliott WM; Bebb G; Flint J; English J; Gilks CB; Grimes HL
J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer.
Park SY; Cho A; Yu WS; Lee CY; Lee JG; Kim DJ; Chung KY
J Nucl Med; 2015 Jan; 56(1):45-9. PubMed ID: 25525185
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
28. Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.
Sun R; Liu Z; Ma G; Lv W; Zhao X; Lei G; Xu C
Int J Clin Exp Pathol; 2015; 8(3):2392-9. PubMed ID: 26045746
[TBL] [Abstract][Full Text] [Related]
29. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
[TBL] [Abstract][Full Text] [Related]
30. The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures.
Fan J; Wang L; Jiang GN; He WX; Ding JA
Lung Cancer; 2008 Jul; 61(1):91-6. PubMed ID: 18192073
[TBL] [Abstract][Full Text] [Related]
31. Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non-small-cell lung cancer.
Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Taniguchi T; Yokoi K; Osada H; Sekido Y
J Surg Res; 2013 Jan; 179(1):24-32. PubMed ID: 22985775
[TBL] [Abstract][Full Text] [Related]
32. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
Bonnesen B; Pappot H; Holmstav J; Skov BG
Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and clinicopathological significance of downregulated E-cadherin expression in patients with non-small cell lung cancer (NSCLC): a meta-analysis.
Yang YL; Chen MW; Xian L
PLoS One; 2014; 9(6):e99763. PubMed ID: 24978478
[TBL] [Abstract][Full Text] [Related]
35. Fasting blood glucose level and prognosis in non-small cell lung cancer (NSCLC) patients.
Luo J; Chen YJ; Chang LJ
Lung Cancer; 2012 May; 76(2):242-7. PubMed ID: 22112292
[TBL] [Abstract][Full Text] [Related]
36. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
Xu TP; Shen H; Liu LX; Shu YQ
Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and prognostic significances of MUC5B and TTF-1 expressions in resected non-small cell lung cancer.
Nagashio R; Ueda J; Ryuge S; Nakashima H; Jiang SX; Kobayashi M; Yanagita K; Katono K; Satoh Y; Masuda N; Murakumo Y; Hachimura K; Sato Y
Sci Rep; 2015 Mar; 5():8649. PubMed ID: 25733373
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Impact of Tissue Inhibitor of Metalloproteinase-1 in Non- Small Cell Lung Cancer: Systematic Review and Meta-Analysis.
Selvaraj G; Kaliamurthi S; Lin S; Gu K; Wei DQ
Curr Med Chem; 2019; 26(42):7694-7713. PubMed ID: 30182835
[TBL] [Abstract][Full Text] [Related]
39. Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis.
Steels E; Paesmans M; Berghmans T; Branle F; Lemaitre F; Mascaux C; Meert AP; Vallot F; Lafitte JJ; Sculier JP
Eur Respir J; 2001 Oct; 18(4):705-19. PubMed ID: 11716177
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of SOX2 expression in non-small cell lung cancer: a meta-analysis.
Chen Y; Huang Y; Huang Y; Chen J; Wang S; Zhou J
PLoS One; 2013; 8(8):e71140. PubMed ID: 23990933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
